MedTrace Logo

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

NCT05937711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-07-10

No results posted yet for this study

Summary

This study aimed to investigate the effectiveness of posterior tibial nerve stimulation (PTNS) in reducing pain, improving quality of life, and decreasing disease severity in patients with fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

OTHER

Transcutaneous Posterior Tibial Nerve Stimulation + Duloxetine 30 MG

PTNS was applied using two 50 mm × 50 mm electrode pads per extremity. The live pad was placed superior to and medial to the medial malleolus. The ground pad was placed 5-10 cm proximal to the live pad. The PTNS was applied using biphasic square waves with a frequency of 10 Hz and pulse duration of 200 μs. The amplitude was adjusted to the level that produced painless paresthesia in each patient according to their tolerance. PTNS was applied for 30 minutes Duloxetine 30 mg p.o 1X1 (daily)

DRUG

Duloxetine 30 MG

Duloxetine 30 mg p.o 1X1 (daily)

Sponsors & Collaborators

  • Ilker Fatih Sari

    lead OTHER

Principal Investigators

  • İlker Fatih Sarı · Giresun University Faculty of Medicine, The Department of Physical Medicine and Rehabilitation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2022-05-23
Completion
2022-05-23

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937711 on ClinicalTrials.gov